Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2 2021-04-28 20:00
CROs dMed and Clinipace Merge to Accelerate Customer Success 2021-04-28 20:00
Turn Biotechnologies completes latest round of funding 2021-04-28 19:50
GenScript Launches Research-Grade Lentiviral Vector Packaging Service 2021-04-28 19:30
Samsung Biologics Reports First Quarter 2021 Financial Results 2021-04-28 16:37
TCI Co., Ltd. becomes Asia's first biotechnology company whose climate ambitions are validated by SBTi 2021-04-27 15:53
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone 2021-04-27 09:23
EpiVax Demonstrates Antigen-Specific Tolerance Induction in Allergy with Tregitopes, Results Published in Frontiers in Immunology 2021-04-27 09:00
Himalaya Therapeutics Announces Appointment of Brian Zhang as Chief Executive Officer 2021-04-26 22:08
PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-04-26 20:00
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis 2021-04-26 19:00
One-Stop CLIA Solution with Open Systems and Resources Makes Evolution to Emerging World Healthcare Systems 2021-04-26 15:17
Associates of Cape Cod, Inc. announces launch of PyroSmart NextGen™ Recombinant LAL Reagent 2021-04-23 22:30
INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800 2021-04-23 20:00
The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review 2021-04-23 15:00
The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to be Granted Priority Review 2021-04-22 21:47
Wuxi Strives to Build a World-class Biomedical Industry Chain 2021-04-22 19:06
RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt 2021-04-22 16:00
Clarivate Releases Predictive Analytics to Help Fuel Life Sciences Deal Making Landscape 2021-04-22 16:00
endpoint Launches ConnectionPOINT™ - A partnership program designed to power accelerated outcomes and move medicine through next-generation eClinical technology interfacing 2021-04-21 21:00
1 247 248 249 250 251 451